Comparison of atogepant vs rimegepant in refractory chronic migraine: A retrospective analysis

被引：0
|
作者：
Baek, William [1 ]
机构：
[1] Parkside Med Grp, Neurol, Upland, CA USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2023年 / 455卷
关键词：
D O I：
10.1016/j.jns.2023.121619
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
121619
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Combined Concordant Peripheral Neurostimulation for Chronic/Refractory Migraine Headaches: A Retrospective Analysis of 188 Consecutive Patients
    Reed, K.
    Conidi, F.
    Will, K.
    Bulger, R.
    Datta, S.
    HEADACHE, 2014, 54 : 47 - 47
  • [22] Refractory migraine and chronic migraine: Pathophysiological mechanisms
    Goadsby, Peter J.
    Hargreaves, Richard
    HEADACHE, 2008, 48 (06): : 799 - 804
  • [23] A retrospective real world evaluation of Fremanezumab (Ajovy) in the management of refractory chronic migraine
    Ghadiri-Sani, Mona
    Broadhurst, Sarah
    Perry, Loouise
    Stockley, Angela M.
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 70 - 70
  • [24] Sustained and Subsequent Response to Atogepant Among Individuals With Chronic Migraine: Post Hoc Analysis of the PROGRESS Trial
    Lipton, R.
    Chalermpalanupap, N.
    Nahas-Geiger, S.
    Pozo-Rosich, P.
    McAllister, P.
    Tatsuoka, Y.
    Liu, Y.
    Dabruzzo, B.
    Smith, J.
    Bilchik, T.
    HEADACHE, 2023, 63 : 168 - 169
  • [25] Post Hoc Analysis of PROGRESS: Evaluating the Safety of Atogepant in Participants With Chronic Migraine and Cardiovascular Risk Factors
    Best, Patricia
    Harriott, Andrea
    Monteith, Teshamae
    Tassorelli, Cristina
    Nahas, Stephanie
    Liu, Yingyi
    Dabruzzo, Brett
    Ferreira, Rosa De Abreu
    Smith, Jonathan H.
    NEUROLOGY, 2023, 100 (17)
  • [26] Post hoc analysis of progress: Evaluating the safety of atogepant in participants with chronic migraine and cardiovascular risk factors
    Best, Patricia
    Harriott, Andrea
    Monteith, Teshamae
    Tassorelli, Cristina
    Nahas, Stephanie
    Davidovic, Goran
    Liu, Yingyi
    Dabruzzo, Brett
    Ferreira, Rosa De Abreu
    Smith, Jonathan
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [27] Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Cook, Lisa
    Rhyne, Christopher
    Jenkins, Brian
    Hughes, Olivia
    Dabruzzo, Brett
    Manack Adams, Aubrey
    Diamond, Merle
    PAIN AND THERAPY, 2024, 13 (06) : 1571 - 1587
  • [28] Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype
    Nagaraj, Karthik
    Wei, Diana Y.
    Puledda, Francesca
    Weng, Hsing-Yu
    Waheed, Sadaf
    Vandenbussche, Nicolas
    Ong, Jonathan J. Y.
    Goadsby, Peter J.
    HEADACHE, 2022, 62 (07): : 828 - 838
  • [29] Atogepant for the Preventive Treatment of Chronic Migraine in Europe: Results From the PROGRESS Study
    Goadsby, P.
    Pozo-Rosich, P.
    Ashina, M.
    Reuter, U.
    Moisset, X.
    Trugman, J.
    Ha, H.
    Schwefel, B.
    Nagy, K.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [30] Network meta-analysis comparing atogepant vs. CGRP mAbs on headache impact test-6 total scores in episodic and chronic migraine
    Ailani, J.
    Dupont-Benjamin, L.
    Ashina, S.
    Takeshima, T.
    Lalla, A.
    Ubamadu, I.
    Pietri, G.
    Gandhi, P.
    Singh, R. B. Halker
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
12345